Stock listing
GPW:NNG NanoGroup SA Akcje
Follow NanoGroup SA into a list and get an email when it puts out news.
Share price · GPW:NNG
2.03 PLN -0.03 (-1.5%)
Close on Nov 20, 2026
- Day range
- 2.03 – 2.09 PLNNov 20, 2026
- Volume
- 40,030 sharesNov 20, 2026
- Market cap
- 86.54M PLNAt the close on Nov 20, 2026 · price × 42.63M shares outstanding
- 52-week range
- 1.98 – 3.20 PLNLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- 88,268 PLNMedian day 24,721 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · GPW:NNG · PLN, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| 2.03 | -0.03 | -1.5% | 2.04 | 2.09 | 2.03 | 40,030 | |
| 2.06 | +0.035 | +1.7% | 2.03 | 2.065 | 2.025 | 24,084 | |
| 2.025 | -0.035 | -1.7% | 2.025 | 2.07 | 2.02 | 85,104 | |
| 2.06 | -0.12 | -5.5% | 2.19 | 2.19 | 2.015 | 169,998 | |
| 2.18 | 0.00 | 0.0% | 2.165 | 2.195 | 1.978 | 112,075 | |
| 2.18 | -0.025 | -1.1% | 2.165 | 2.225 | 2.15 | 45,120 | |
| 2.205 | -0.04 | -1.8% | 2.25 | 2.25 | 2.155 | 38,049 | |
| 2.245 | 0.00 | 0.0% | 2.245 | 2.275 | 2.18 | 69,323 | |
| 2.245 | -0.035 | -1.5% | 2.28 | 2.30 | 2.20 | 49,401 | |
| 2.28 | -0.01 | -0.4% | 2.30 | 2.30 | 2.28 | 7,231 | |
| 2.29 | 0.00 | 0.0% | 2.29 | 2.295 | 2.27 | 6,396 | |
| 2.29 | +0.015 | +0.7% | 2.275 | 2.29 | 2.25 | 8,334 | |
| 2.275 | -0.075 | -3.2% | 2.345 | 2.35 | 2.23 | 43,660 | |
| 2.35 | 0.00 | 0.0% | 2.37 | 2.37 | 2.29 | 12,594 | |
| 2.35 | -0.005 | -0.2% | 2.37 | 2.37 | 2.29 | 10,026 | |
| 2.355 | +0.045 | +1.9% | 2.36 | 2.36 | 2.305 | 6,855 | |
| 2.31 | 0.00 | 0.0% | 2.275 | 2.375 | 2.275 | 7,010 | |
| 2.31 | -0.02 | -0.9% | 2.33 | 2.365 | 2.29 | 8,572 | |
| 2.33 | -0.01 | -0.4% | 2.30 | 2.335 | 2.27 | 18,586 | |
| 2.34 | 0.00 | 0.0% | 2.34 | 2.34 | 2.28 | 6,893 | |
| 2.34 | -0.025 | -1.1% | 2.375 | 2.375 | 2.225 | 46,746 | |
| 2.365 | +0.005 | +0.2% | 2.35 | 2.375 | 2.33 | 9,675 | |
| 2.36 | -0.025 | -1.0% | 2.345 | 2.40 | 2.345 | 7,342 | |
| 2.385 | +0.01 | +0.4% | 2.35 | 2.425 | 2.345 | 7,265 | |
| 2.375 | -0.01 | -0.4% | 2.37 | 2.375 | 2.345 | 13,821 | |
| 2.385 | +0.025 | +1.1% | 2.40 | 2.415 | 2.35 | 19,634 | |
| 2.36 | 0.00 | 0.0% | 2.35 | 2.39 | 2.35 | 22,520 | |
| 2.36 | -0.04 | -1.7% | 2.35 | 2.45 | 2.35 | 24,721 | |
| 2.40 | -0.04 | -1.6% | 2.45 | 2.47 | 2.26 | 74,544 | |
| 2.44 | +0.025 | +1.0% | 2.39 | 2.455 | 2.35 | 16,776 | |
| 2.415 | -0.015 | -0.6% | 2.455 | 2.455 | 2.39 | 12,558 | |
| 2.43 | 0.00 | 0.0% | 2.41 | 2.475 | 2.40 | 29,745 | |
| 2.43 | -0.04 | -1.6% | 2.495 | 2.495 | 2.40 | 16,624 | |
| 2.47 | +0.01 | +0.4% | 2.46 | 2.47 | 2.405 | 9,984 | |
| 2.46 | -0.02 | -0.8% | 2.475 | 2.475 | 2.44 | 18,922 | |
| 2.48 | 0.00 | 0.0% | 2.48 | 2.495 | 2.415 | 12,735 | |
| 2.48 | -0.02 | -0.8% | 2.495 | 2.50 | 2.43 | 25,150 | |
| 2.50 | 0.00 | 0.0% | 2.50 | 2.50 | 2.465 | 34,232 | |
| 2.50 | 0.00 | 0.0% | 2.475 | 2.50 | 2.45 | 11,800 | |
| 2.50 | +0.005 | +0.2% | 2.495 | 2.50 | 2.46 | 44,480 | |
| 2.495 | +0.01 | +0.4% | 2.485 | 2.50 | 2.46 | 41,844 | |
| 2.485 | +0.005 | +0.2% | 2.45 | 2.50 | 2.45 | 87,614 | |
| 2.48 | +0.015 | +0.6% | 2.49 | 2.49 | 2.45 | 59,924 | |
| 2.465 | -0.03 | -1.2% | 2.49 | 2.49 | 2.43 | 57,969 | |
| 2.495 | +0.105 | +4.4% | 2.44 | 2.52 | 2.39 | 108,701 | |
| 2.39 | -0.025 | -1.0% | 2.39 | 2.46 | 2.39 | 27,638 | |
| 2.415 | -0.045 | -1.8% | 2.465 | 2.47 | 2.385 | 26,476 | |
| 2.46 | -0.03 | -1.2% | 2.51 | 2.515 | 2.41 | 74,907 | |
| 2.49 | -0.015 | -0.6% | 2.47 | 2.51 | 2.46 | 40,638 | |
| 2.505 | -0.035 | -1.4% | 2.52 | 2.525 | 2.445 | 69,630 | |
| 2.54 | 0.00 | 0.0% | 2.55 | 2.56 | 2.50 | 105,653 | |
| 2.54 | +0.10 | +4.1% | 2.445 | 2.545 | 2.41 | 207,494 | |
| 2.44 | +0.015 | +0.6% | 2.43 | 2.47 | 2.37 | 27,951 | |
| 2.425 | +0.015 | +0.6% | 2.41 | 2.49 | 2.35 | 45,416 | |
| 2.41 | +0.025 | +1.0% | 2.39 | 2.42 | 2.31 | 30,167 | |
| 2.385 | -0.055 | -2.3% | 2.445 | 2.475 | 2.38 | 23,774 | |
| 2.44 | -0.035 | -1.4% | 2.48 | 2.48 | 2.395 | 16,303 | |
| 2.475 | +0.03 | +1.2% | 2.445 | 2.50 | 2.40 | 43,932 | |
| 2.445 | +0.04 | +1.7% | 2.405 | 2.45 | 2.395 | 3,706 | |
| 2.405 | -0.025 | -1.0% | 2.425 | 2.47 | 2.38 | 11,226 | |
| 2.43 | +0.05 | +2.1% | 2.43 | 2.435 | 2.39 | 6,397 | |
| 2.38 | -0.09 | -3.6% | 2.475 | 2.475 | 2.38 | 40,146 | |
| 2.47 | +0.005 | +0.2% | 2.46 | 2.475 | 2.41 | 13,005 | |
| 2.465 | -0.03 | -1.2% | 2.415 | 2.49 | 2.41 | 13,147 | |
| 2.495 | +0.005 | +0.2% | 2.475 | 2.50 | 2.475 | 10,505 |
- Ticker
- GPW:NNG
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- GPW
- Currency
- PLN
What changed lately
Latest deck · May 2026
Corporate Update (May 2026)
Corporate update · 17 slides
NanoGroup SA on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- Decks
- 3 decks · latest May 2026
Valuation
Price/book 4.0× against a median of 1.6×: 7th lowest of 9 Biotechnology companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026
- Enterprise value
- 76.26M PLN
- P/E
- Loss
- EV/sales
- No revenue
- EV/EBITDA
- Negative EBITDA
- Price/book
- 4.0×
- Gross margin
- No revenue
- Operating margin
- No revenue
- Net margin
- No revenue
- Debt to equity
- 0.0×
- Beta
- No index for this market yet
Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| NanoGroup SA · GPW:NNG | US$21.32M | US$18.78M | n/a | n/a | n/a | 4.0× | n/a | 0.0× | n/a |
| ME Therapeutics Holdings, Inc. · CSE:METX | US$22.25M | US$21.88M | n/a | n/a | n/a | 49.5× | n/a | 0.0× | 0.52 |
| CervoMed Inc. · NASDAQ:CRVO | US$22.09M | US$2.49M | n/a | 285× | n/a | 1.3× | n/a | 0.0× | 1.97 |
| Sona Nanotech, Inc. · CSE:SONA | US$21.84M | US$22.06M | n/a | n/a | n/a | n/a | n/a | n/a | 0.47 |
| Mendus AB · OMXSTO:IMMU | US$21.76M | US$17.65M | n/a | n/a | n/a | 0.4× | n/a | 0.0× | n/a |
| Metagenomi Therapeutics, Inc. · NASDAQ:MGX | US$21.36M | −US$44.10M | n/a | −6.2× | n/a | 0.2× | n/a | 0.4× | 1.65 |
| Cel-Sci Corporation · AMEX:CVM | US$21.28M | US$14.76M | n/a | n/a | n/a | 1.9× | n/a | 0.0× | 1.13 |
| ZYUS Life Sciences Corporation · TSXV:ZYUS | US$20.92M | US$25.65M | n/a | 98.4× | n/a | n/a | n/a | n/a | -0.02 |
| Xbrane Biopharma AB · OMXSTO:XBRANE | US$20.88M | US$23.48M | n/a | 1.9× | n/a | 0.4× | −49.0% | 0.1× | n/a |
| Vivoryon Therapeutics N.V. · EURONEXT:VVY | US$20.48M | US$17.77M | n/a | n/a | n/a | 11.9× | n/a | 0.1× | n/a |
| Evaxion A/S · NASDAQ:EVAX | US$20.30M | US$13.40M | n/a | 1.8× | n/a | 2.1× | −115.1% | 0.8× | 0.78 |
| Median of the others | US$21.32M | US$17.71M | 1.9× | 1.6× | −82.1% | 0.0× | 0.78 |
Team and board
| Director | Role |
|---|---|
| Jakub Tatak | Członek Rady Nadzorczej |
| Jerzy Garlicki | Przewodniczący Rady Nadzorczej |
| Łukasz Gołębiewski | Członek Rady Nadzorczej |
| Piotr Mierzejewski | Wiceprezes Zarządu |
| Przemysław Mazurek | Prezes Zarządu |
| Rafał Płókarz | Członek Rady Nadzorczej |
| Tadeusz Wesołowski | Członek Rady Nadzorczej |
| Tomasz Ciach | Założyciel, Członek Zarządu |
| Tomasz Zastawny | Członek Rady Nadzorczej |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Corporate Update (May 2026) | Corporate update | 17 slides | May 2026 |
| Fact Sheet (October 2020) | Fact sheet | 3 slides | October 2020 |
| IPO Roadshow (October 2017) | IPO roadshow | 19 slides | October 2017 |
Financials
Annual, in PLN
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 2.10K | 2.02K | 139.5K | 492.5K | 687.5K | 351.8K | 110.3K | 40.8K | |
| Cost of revenue | 111.5K | 46.6K | 81.0K | 95.8K | 185.9K | 31.2K | 18.3K | 25.6K | 86.8K | 58.4K |
| Gross profit | -111.5K | -44.5K | -79.0K | 43.8K | 306.6K | 656.3K | 333.6K | 84.7K | -46.0K | -58.4K |
| Research and development | 454.6K | 12.1M | 1.20M | 5.11M | ||||||
| Selling, general and administrative | 1.72M | 848.9K | 711.8K | 1.32M | 1.10M | 456.0K | ||||
| Operating income | -9.58M | -5.18M | -7.90M | -784.6K | -10.6M | -3.26M | -1.71M | -2.41M | -2.01M | -951.0K |
| Depreciation and amortization | 111.5K | 34.9K | 35.4K | 62.2K | 64.3K | 156.6K | 215.2K | 55.3K | 54.2K | 35.6K |
| EBITDA | -9.46M | -5.14M | -7.87M | -722.4K | -10.5M | -3.11M | -1.49M | -2.35M | -1.96M | -915.4K |
| Interest expense | 14 | 1.09K | 4.52K | 1.36K | 108.1K | 31.8K | 51.4K | 19.3K | 24.3K | 20.9K |
| Income before tax | -9.58M | -5.22M | -7.91M | -783.5K | -10.7M | -5.24M | -1.54M | -2.42M | -2.03M | -936.0K |
| Income tax | 34.4K | 0 | -12.0K | -12.0K | 65.5K | 24.0K | -5.54K | -3.18K | -170.8K | |
| Net income | -9.45M | -5.17M | -7.89M | -838.6K | -10.0M | -5.19M | -1.54M | -2.34M | -2.01M | -786.1K |
| Earnings per share, basic | -0.29 | -0.16 | -0.39 | -0.05 | -0.64 | -0.31 | -0.11 | -0.18 | -0.15 | -0.07 |
| Earnings per share, diluted | -0.33 | -0.04 | -0.61 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 15.5M | 7.83M | 537.6K | 2.47M | 4.00M | 10.3M | 1.92M | 4.57M | 5.57M | 9.31M |
| Short-term investments | 1.27M | 1.55M | 102.2K | |||||||
| Receivables | 548.1K | 205.2K | 57.9K | 57.8K | 523.7K | 540.1K | 7.20K | 6.76K | 14.7K | |
| Inventory | 91.3K | 36.2K | 63.4K | 46.5K | 48.4K | 433 | 11.2K | 3.30K | ||
| Current assets | 16.2M | 9.42M | 836.1K | 2.93M | 5.08M | 11.1M | 2.26M | 4.88M | 6.25M | 9.68M |
| Property, plant and equipment | 485.9K | 295.5K | 432.1K | 1.04M | 1.27M | 789.9K | 1.27M | |||
| Goodwill | 0 | 0 | 0 | 0 | 0 | 2.40M | 4.38M | 5.57M | 5.35M | 5.05M |
| Total assets | 40.6M | 19.9M | 8.63M | 19.2M | 20.3M | 30.0M | 26.4M | 27.0M | 22.6M | 19.5M |
| Accounts payable | 588.7K | 100.5K | 194.2K | 202.7K | 280.2K | 130.4K | 75.2K | 94.8K | 1.40M | 187.4K |
| Current liabilities | 20.6M | 799.7K | 1.49M | 1.42M | 4.50M | 782.5K | 523.3K | 563.9K | 2.48M | 3.92M |
| Long-term debt | 285.3K | 430.7K | 35.1K | |||||||
| Total debt | 139.2K | 285.3K | 612.5K | 652.1K | 45.6K | 69.4K | ||||
| Total liabilities | 20.6M | 4.01M | 3.47M | 11.4M | 11.9M | 11.3M | 13.1M | 11.5M | 8.44M | 6.70M |
| Shareholders' equity | 9.25M | 15.2M | 4.48M | 7.08M | 7.73M | 17.7M | 12.3M | 14.2M | 12.8M | 11.4M |
| Shares outstanding | 32.8M | 31.6M | 20.1M | 16.7M | 16.7M | 16.7M | 14.0M | 13.0M | 13.0M | 12.0M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -8.80M | -5.72M | -4.76M | -3.68M | -2.65M | -1.35M | -1.58M | -3.47M | -2.60M | -772.1K |
| Capital spending | -1.17M | -191.9K | -75.9K | -8.41K | -50.0K | -2.17M | -2.82M | -5.86M | -9.12M | -2.08M |
| Free cash flow | -9.97M | -5.91M | -4.84M | -3.69M | -2.70M | -3.51M | -4.40M | -9.33M | -11.7M | -2.85M |
| Cash from investing | -13.3M | -4.58M | -3.66M | -806.9K | -3.87M | -2.01M | -2.40M | -5.86M | -9.12M | -2.07M |
| Cash from financing | 29.7M | 17.6M | 6.48M | 2.96M | 749.2K | 11.8M | 1.32M | 8.33M | 7.98M | 8.16M |
| Share buybacks | 0 | 0 | 11.4M | 3.55M | 3.83M | |||||
| Change in cash | 7.63M | 7.29M | -1.93M | -1.53M | -5.78M | 8.40M | -2.65M | -1.00M | -3.73M | 5.32M |
Cap table
Built by 6ix from NanoGroup SA’s releases
- Common shares
- 42,628,988
- Fully diluted
- 42,628,988
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 42,628,988 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 42,628,988 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Jakub Tatak | Członek Rady Nadzorczej · Since at least Nov 5, 2026 |
| Jerzy Garlicki | Przewodniczący Rady Nadzorczej · Since at least Nov 5, 2026 |
| Łukasz Gołębiewski | Członek Rady Nadzorczej · Since at least Nov 5, 2026 |
| Piotr Mierzejewski | Wiceprezes Zarządu · Since at least Nov 5, 2026 |
| Przemysław Mazurek | Prezes Zarządu · Since at least Nov 5, 2026 |
| Rafał Płókarz | Członek Rady Nadzorczej · Since at least Nov 5, 2026 |
| Tadeusz Wesołowski | Członek Rady Nadzorczej · Since at least Nov 5, 2026 |
| Tomasz Ciach | Założyciel, Członek Zarządu · Since at least Nov 5, 2026 |
| Tomasz Zastawny | Członek Rady Nadzorczej · Since at least Nov 5, 2026 |
Log in to ask 6ix AI your own questions about NanoGroup SA.